Label Changes for:

Avelox (moxifloxacin hydrochloride) Tablets and IV

October 2011

Changes have been made to the WARNINGS and PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – October 2011

 

 

Avelox (moxifloxacin hydrochloride) Tablets and IV

 

WARNINGS AND PRECAUTIONS

Central Nervous System Effects/ Disorders
  • Convulsions and increased intracranial pressure (including pseudotumor cerebri) have been reported...
Hide
(web1)